GenVec Inc (NASDAQ:GNVC)
| 0.66 Real-Time Quote |  0.00 / 0.00%Today’s Change | 0.63 Today|||52-Week Range 2.78 | -50.75% Year-to-Date |
Latest GNVC News | Press Releases
No recent news for GenVec Inc.
Today’s Trading
| Previous close | 0.66 |
| Today’s open | 0.63 |
| Day’s range | 0.63 - 0.69 |
| Volume | 50,432 |
| Average volume (3 months) | 67,303 |
| Market cap | $8.5M |
| Dividend yield | -- |
Data as of 1:03pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | -87.93% |
| Earnings growth (this year) | +42.20% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -47.29% |
| P/E ratio | NM |
| Price/Sales | 1.85 |
| Price/Book | 0.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABIOARCA Biopharma Inc | -0.14 | -5.47% |
| BSPMBiostar Pharmaceutic... | -0.07 | -9.09% |
| CPHIChina Pharma Holding... | +0.00 | +0.76% |
| TLONTalon Therapeutics I... | 0.00 | 0.00% |
Data as of 12:48pm ET, 05/20/2013
Financials
| Last reporting date | May 20, 2013 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $9.4M |
| Annual profit (last year) | -$14.1M |
| Net profit margin | -150.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Cynthia L. Collins, MBA |
CFO, Secretary, Treasurer & Senior Vice President Douglas J. Swirsky, MBA, CPA |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
